Back
Cyclacel Pharmaceuticals Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
33
CYCC
Cyclacel Pharmaceuticals
Last Price:
$8.30
Seasonality Move:
-9.19%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is relatively stagnant and CYCC is experiencing selling pressure, which indicates risk of future bearish movement.
Cyclacel Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.3 | Buy |
| 20-day SMA: | 5.05 | Buy |
| 50-day SMA: | 19.98 | Sell |
| 200-day SMA: | 83.95 | Sell |
| 8-day EMA: | 6.29 | Buy |
| 20-day EMA: | 7.11 | Buy |
| 50-day EMA: | 19.24 | Sell |
| 200-day EMA: | 138.6 | Sell |
Cyclacel Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.03 | Sell |
| Relative Strength Index (14 RSI): | 47.4 | Sell |
| Chaikin Money Flow: | -1783527 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.25 - 6.87) | Buy |
| Bollinger Bands (100): | (14.5 - 72.58) | Sell |
Cyclacel Pharmaceuticals Technical Analysis
| Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Cyclacel Pharmaceuticals Stock
Is Cyclacel Pharmaceuticals Stock a Buy?
-
Cyclacel Pharmaceuticals share price is 8.20 while CYCC 8-day simple moving average is 5.30, which is a Buy signal.
-
The stock price of CYCC is 8.20 while Cyclacel Pharmaceuticals 20-day SMA is 5.05, which makes it a Buy.
-
Cyclacel Pharmaceuticals 50-day simple moving average is 19.98 while CYCC share price is 8.20, making it a Sell technically.
-
CYCC stock price is 8.20 and Cyclacel Pharmaceuticals 200-day simple moving average is 83.95, creating a Sell signal.
CYCC Technical Analysis vs Fundamental Analysis
Sell
33
Cyclacel Pharmaceuticals (CYCC)
is a Sell
Is Cyclacel Pharmaceuticals a Buy or a Sell?
-
Cyclacel Pharmaceuticals stock is rated a SellThe current Cyclacel Pharmaceuticals [CYCC] share price is $8.20. The Score for CYCC is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
Cyclacel Pharmaceuticals Stock Info
Market Cap:
13M
Price in USD:
8.20
Share Volume:
3.6M
Cyclacel Pharmaceuticals 52-Week Range
52-Week High:
597.60
52-Week Low:
3.08
Sell
33
Cyclacel Pharmaceuticals (CYCC)
is a Sell
Cyclacel Pharmaceuticals Share Price Forecast
-
What is the Cyclacel Pharmaceuticals stock price today?The Cyclacel Pharmaceuticals stock price is 8.20 USD today.
-
Will CYCC stock go up or go down?Cyclacel Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Cyclacel Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cyclacel Pharmaceuticals is overvalued.
Is Cyclacel Pharmaceuticals Stock a Buy?
-
Cyclacel Pharmaceuticals share price is 8.20 while CYCC 8-day exponential moving average is 6.29, which is a Buy signal.
-
The stock price of CYCC is 8.20 while Cyclacel Pharmaceuticals 20-day EMA is 7.11, which makes it a Buy.
-
Cyclacel Pharmaceuticals 50-day exponential moving average is 19.24 while CYCC share price is 8.20, making it a Sell technically.
-
CYCC stock price is 8.20 and Cyclacel Pharmaceuticals 200-day simple moving average is 138.60, creating a Sell signal.
Fundamental Analysis of Cyclacel Pharmaceuticals
Is Cyclacel Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $129.30 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.77 per share, and an increase next year of $0.06 per share.
Technical Analysis of Cyclacel Pharmaceuticals
Should I short Cyclacel Pharmaceuticals stock?
-
CYCC Moving Average Covergence Divergence (MACD) indicator is -3.03, suggesting Cyclacel Pharmaceuticals is a Sell
-
Cyclacel Pharmaceuticals Relative Strength Index (RSI) is 47.4, which suggest Cyclacel Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Cyclacel Pharmaceuticals is (3.25 - 6.87), which suggest Cyclacel Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Cyclacel Pharmaceuticals is (14.5 - 72.58), which suggest Cyclacel Pharmaceuticals is a Sell
* Cyclacel Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.